( 0 1 0 1 O
Postmenopausal 1 15 1 15 O
woman 16 21 16 21 B-gender
must 22 26 22 26 O
have 27 31 27 31 O
been 32 36 32 36 O
amenorrheic 37 48 37 48 B-clinical_variable
for 49 52 49 52 O
at 53 55 53 55 O
least 56 61 56 61 O
12 62 64 62 64 B-lower_bound
months 65 71 65 71 I-lower_bound
to 72 74 72 74 O
be 75 77 75 77 O
considered 78 88 78 88 O
of 89 91 89 91 O
non 92 95 92 95 O
- 95 96 95 96 O
childbearing 96 108 96 108 O
potential 109 118 109 118 O
) 118 119 118 119 O

Age 0 3 120 123 B-age
18 4 6 124 126 B-lower_bound
or 7 9 127 129 O
greater 10 17 130 137 O

Bilirubin 0 9 138 147 B-clinical_variable
< 10 11 148 149 O
1.5 12 15 150 153 B-upper_bound
mg 16 18 154 156 I-upper_bound
/ 18 19 156 157 I-upper_bound
dL 19 21 157 159 I-upper_bound

Concurrent 0 10 160 170 O
treatment 11 20 171 180 B-treatment
with 21 25 181 185 O
other 26 31 186 191 O
anticancer 32 42 192 202 B-treatment
therapy 43 50 203 210 I-treatment
, 50 51 210 211 O
including 52 61 212 221 O
other 62 67 222 227 O
chemotherapy 68 80 228 240 B-treatment
, 80 81 240 241 O
immunotherapy 82 95 242 255 B-treatment
, 95 96 255 256 O
hormonal 97 105 257 265 B-treatment
therapy 106 113 266 273 I-treatment
, 113 114 273 274 O
radiotherapy 115 127 275 287 B-treatment
, 127 128 287 288 O
chemo 129 134 289 294 B-treatment
- 134 135 294 295 I-treatment
embolization 135 147 295 307 I-treatment
, 147 148 307 308 O
targeted 149 157 309 317 B-treatment
therapy 158 165 318 325 I-treatment
, 165 166 325 326 O
or 167 169 327 329 O
an 170 172 330 332 O
investigational 173 188 333 348 B-treatment
agent 189 194 349 354 I-treatment

ECOG 0 4 355 359 B-clinical_variable
performance 5 16 360 371 I-clinical_variable
status 17 23 372 378 I-clinical_variable
> 24 25 379 380 O
1 25 26 380 381 B-lower_bound

ECOG 0 4 382 386 B-clinical_variable
performance 5 16 387 398 I-clinical_variable
status 17 23 399 405 I-clinical_variable
of 24 26 406 408 O
0 27 28 409 410 B-lower_bound
- 28 29 410 411 O
1 29 30 411 412 B-upper_bound

First 0 5 413 418 B-treatment
- 5 6 418 419 I-treatment
line 6 10 419 423 I-treatment
treatment 11 20 424 433 I-treatment
with 21 25 434 438 O
a 26 27 439 440 O
standard 28 36 441 449 O
platinum 37 45 450 458 B-treatment
doublet 46 53 459 466 I-treatment
chemotherapy 54 66 467 479 I-treatment
regimen 67 74 480 487 O
( 75 76 488 489 O
carboplatin 76 87 489 500 B-treatment
or 88 90 501 503 O
cisplatin 91 100 504 513 B-treatment
at 101 103 514 516 O
standard 104 112 517 525 O
dosing 113 119 526 532 O
plus 120 124 533 537 O
one 125 128 538 541 O
of 129 131 542 544 O
the 132 135 545 548 O
following 136 145 549 558 O
drugs 146 151 559 564 O
at 152 154 565 567 O
standard 155 163 568 576 O
dosing 164 170 577 583 O
: 170 171 583 584 O
paclitaxel 172 182 585 595 B-treatment
, 182 183 595 596 O
docetaxel 184 193 597 606 B-treatment
, 193 194 606 607 O
vinblastine 195 206 608 619 B-treatment
, 206 207 619 620 O
vinorelbine 208 219 621 632 B-treatment
, 219 220 632 633 O
pemetrexed 221 231 634 644 B-treatment
, 231 232 644 645 O
or 233 235 646 648 O
etoposide 236 245 649 658 B-treatment
) 245 246 658 659 O

Histologic 0 10 660 670 B-cancer
or 11 13 671 673 O
cytologic 14 23 674 683 O
diagnosis 24 33 684 693 O
of 34 36 694 696 O
adenocarcinoma 37 51 697 711 B-cancer
non 52 55 712 715 B-cancer
- 55 56 715 716 I-cancer
small 56 61 716 721 I-cancer
cell 62 66 722 726 I-cancer
lung 67 71 727 731 I-cancer
cancer 72 78 732 738 I-cancer

Known 0 5 739 744 O
HIV 6 9 745 748 B-chronic_disease
or 10 12 749 751 O
Hepatitis 13 22 752 761 B-chronic_disease
C 23 24 762 763 I-chronic_disease

Life 0 4 764 768 B-clinical_variable
expectancy 5 15 769 779 I-clinical_variable
of 16 18 780 782 O
at 19 21 783 785 O
least 22 27 786 791 O
12 28 30 792 794 B-lower_bound
weeks 31 36 795 800 I-lower_bound

Men 0 3 801 804 B-gender
and 4 7 805 808 O
women 8 13 809 814 B-gender
of 14 16 815 817 O
reproductive 17 29 818 830 O
potential 30 39 831 840 O
may 40 43 841 844 O
not 44 47 845 848 O
participate 48 59 849 860 O
in 60 62 861 863 O
this 63 67 864 868 O
study 68 73 869 874 O
unless 74 80 875 881 O
they 81 85 882 886 O
have 86 90 887 891 O
agreed 91 97 892 898 B-contraception_consent
to 98 100 899 901 I-contraception_consent
use 101 104 902 905 I-contraception_consent
an 105 107 906 908 I-contraception_consent
effective 108 117 909 918 I-contraception_consent
contraceptive 118 131 919 932 I-contraception_consent
method 132 138 933 939 I-contraception_consent
while 139 144 940 945 O
in 145 147 946 948 O
this 148 152 949 953 O
study 153 158 954 959 O

Must 0 4 960 964 O
have 5 9 965 969 O
measurable 10 20 970 980 O
disease 21 28 981 988 O
defined 29 36 989 996 O
as 37 39 997 999 O
at 40 42 1000 1002 O
least 43 48 1003 1008 O
one 49 52 1009 1012 B-lower_bound
lesion 53 59 1013 1019 O
that 60 64 1020 1024 O
can 65 68 1025 1028 O
be 69 71 1029 1031 O
accurately 72 82 1032 1042 O
measured 83 91 1043 1051 O
in 92 94 1052 1054 O
at 95 97 1055 1057 O
least 98 103 1058 1063 O
one 104 107 1064 1067 O
dimension 108 117 1068 1077 O
( 118 119 1078 1079 O
longest 119 126 1079 1086 O
diameter 127 135 1087 1095 O
to 136 138 1096 1098 O
be 139 141 1099 1101 O
recorded 142 150 1102 1110 O
as 151 153 1111 1113 O
> 154 155 1114 1115 O
20 156 158 1116 1118 B-lower_bound
mm 159 161 1119 1121 I-lower_bound
with 162 166 1122 1126 O
conventional 167 179 1127 1139 B-treatment
techniques 180 190 1140 1150 I-treatment
or 191 193 1151 1153 O
> 194 195 1154 1155 O
10 196 198 1156 1158 B-lower_bound
mm 199 201 1159 1161 I-lower_bound
with 202 206 1162 1166 O
spiral 207 213 1167 1173 B-treatment
CT 214 216 1174 1176 I-treatment
scanning 217 225 1177 1185 I-treatment
) 225 226 1185 1186 O

Must 0 4 1187 1191 O
have 5 9 1192 1196 O
recovered 10 19 1197 1206 O
from 20 24 1207 1211 O
toxic 25 30 1212 1217 O
effects 31 38 1218 1225 O
of 39 41 1226 1228 O
prior 42 47 1229 1234 B-treatment
chemotherapy 48 60 1235 1247 I-treatment

Negative 0 8 1248 1256 B-pregnancy
serum 9 14 1257 1262 I-pregnancy
Î² 15 16 1263 1264 I-pregnancy
- 16 17 1264 1265 I-pregnancy
hCG 17 20 1265 1268 I-pregnancy
pregnancy 21 30 1269 1278 I-pregnancy
test 31 35 1279 1283 O
at 36 38 1284 1286 O
screening 39 48 1287 1296 O
for 49 52 1297 1300 O
patients 53 61 1301 1309 O
of 62 64 1310 1312 O
childbearing 65 77 1313 1325 O
potential 78 87 1326 1335 O

Patients 0 8 1336 1344 O
must 9 13 1345 1349 O
agree 14 19 1350 1355 B-contraception_consent
to 20 22 1356 1358 I-contraception_consent
continue 23 31 1359 1367 I-contraception_consent
contraception 32 45 1368 1381 I-contraception_consent
for 46 49 1382 1385 O
3 50 51 1386 1387 B-upper_bound
months 52 58 1388 1394 I-upper_bound
from 59 63 1395 1399 O
the 64 67 1400 1403 O
date 68 72 1404 1408 O
of 73 75 1409 1411 O
the 76 79 1412 1415 O
last 80 84 1416 1420 O
study 85 90 1421 1426 B-treatment
drug 91 95 1427 1431 I-treatment
administration 96 110 1432 1446 O

Patients 0 8 1447 1455 O
must 9 13 1456 1460 O
be 14 16 1461 1463 O
capable 17 24 1464 1471 O
of 25 27 1472 1474 O
giving 28 34 1475 1481 O
informed 35 43 1482 1490 O
consent 44 51 1491 1498 O
and 52 55 1499 1502 O
be 56 58 1503 1505 O
willing 59 66 1506 1513 O
and 67 70 1514 1517 O
able 71 75 1518 1522 O
to 76 78 1523 1525 O
comply 79 85 1526 1532 O
with 86 90 1533 1537 O
scheduled 91 100 1538 1547 O
visits 101 107 1548 1554 O
, 107 108 1554 1555 O
treatment 109 118 1556 1565 B-treatment
plan 119 123 1566 1570 O
and 124 127 1571 1574 O
laboratory 128 138 1575 1585 O
testing 139 146 1586 1593 O

Patients 0 8 1594 1602 O
must 9 13 1603 1607 O
have 14 18 1608 1612 O
< 19 20 1613 1614 O
Grade 21 26 1615 1620 B-upper_bound
2 27 28 1621 1622 I-upper_bound
pre 29 32 1623 1626 O
- 32 33 1626 1627 O
existing 33 41 1627 1635 O
peripheral 42 52 1636 1646 B-clinical_variable
neuropathy 53 63 1647 1657 I-clinical_variable
( 64 65 1658 1659 O
per 65 68 1659 1662 O
CTCAE 69 74 1663 1668 O
) 74 75 1668 1669 O

Patients 0 8 1670 1678 O
must 9 13 1679 1683 O
have 14 18 1684 1688 O
adequate 19 27 1689 1697 O
bone 28 32 1698 1702 O
marrow 33 39 1703 1709 O
function 40 48 1710 1718 O
: 48 49 1718 1719 O
Platelets 50 59 1720 1729 B-clinical_variable
> 60 61 1730 1731 O
100,000 61 68 1731 1738 B-lower_bound
cells 69 74 1739 1744 I-lower_bound
/ 74 75 1744 1745 I-lower_bound
mm3 75 78 1745 1748 I-lower_bound
, 78 79 1748 1749 O
Hemoglobin 80 90 1750 1760 B-clinical_variable
> 91 92 1761 1762 O
9.0g 93 97 1763 1767 B-lower_bound
/ 97 98 1767 1768 I-lower_bound
dL 98 100 1768 1770 I-lower_bound
and 101 104 1771 1774 O
ANC 105 108 1775 1778 B-clinical_variable
> 109 110 1779 1780 O
1,500 111 116 1781 1786 B-lower_bound
cells 117 122 1787 1792 I-lower_bound
/ 122 123 1792 1793 I-lower_bound
mm3 123 126 1793 1796 I-lower_bound

Patients 0 8 1797 1805 O
must 9 13 1806 1810 O
have 14 18 1811 1815 O
adequate 19 27 1816 1824 O
liver 28 33 1825 1830 O
function 34 42 1831 1839 O
: 42 43 1839 1840 O
AST 44 47 1841 1844 B-clinical_variable
and 48 51 1845 1848 I-clinical_variable
ALT 52 55 1849 1852 I-clinical_variable
< 56 57 1853 1854 O
2.5 58 61 1855 1858 B-upper_bound
X 62 63 1859 1860 I-upper_bound
upper 64 69 1861 1866 I-upper_bound
limit 70 75 1867 1872 I-upper_bound
of 76 78 1873 1875 I-upper_bound
normal 79 85 1876 1882 I-upper_bound
, 85 86 1882 1883 O
alkaline 87 95 1884 1892 B-clinical_variable
phosphatase 96 107 1893 1904 I-clinical_variable
< 108 109 1905 1906 O
2.5 110 113 1907 1910 O
X 114 115 1911 1912 O
upper 116 121 1913 1918 O
limit 122 127 1919 1924 O
of 128 130 1925 1927 O
normal 131 137 1928 1934 O
, 137 138 1934 1935 O
unless 139 145 1936 1942 O
bone 146 150 1943 1947 B-cancer
metastasis 151 161 1948 1958 I-cancer
is 162 164 1959 1961 O
present 165 172 1962 1969 O
in 173 175 1970 1972 O
the 176 179 1973 1976 O
absence 180 187 1977 1984 O
of 188 190 1985 1987 O
liver 191 196 1988 1993 B-cancer
metastasis 197 207 1994 2004 I-cancer

Patients 0 8 2005 2013 O
must 9 13 2014 2018 O
have 14 18 2019 2023 O
adequate 19 27 2024 2032 O
renal 28 33 2033 2038 O
function 34 42 2039 2047 O
: 42 43 2047 2048 O
creatinine 44 54 2049 2059 B-clinical_variable
< 55 56 2060 2061 O
1.5 56 59 2061 2064 B-upper_bound
mg 60 62 2065 2067 I-upper_bound
/ 62 63 2067 2068 I-upper_bound
dL 63 65 2068 2070 I-upper_bound

Patients 0 8 2071 2079 O
previously 9 19 2080 2090 O
treated 20 27 2091 2098 O
with 28 32 2099 2103 O
gemcitabine 33 44 2104 2115 B-treatment
or 45 47 2116 2118 O
Abraxane 48 56 2119 2127 B-treatment

Patients 0 8 2128 2136 O
who 9 12 2137 2140 O
received 13 21 2141 2149 O
platinum 22 30 2150 2158 B-treatment
- 30 31 2158 2159 I-treatment
based 31 36 2159 2164 I-treatment
chemotherapy 37 49 2165 2177 I-treatment
for 50 53 2178 2181 O
localized 54 63 2182 2191 O
lung 64 68 2192 2196 B-cancer
cancer 69 75 2197 2203 I-cancer
( 76 77 2204 2205 O
either 77 83 2205 2211 O
adjuvant 84 92 2212 2220 B-treatment
chemotherapy 93 105 2221 2233 I-treatment
following 106 115 2234 2243 O
surgery 116 123 2244 2251 B-treatment
or 124 126 2252 2254 O
chemotherapy 127 139 2255 2267 O
given 140 145 2268 2273 O
in 146 148 2274 2276 O
conjunction 149 160 2277 2288 O
with 161 165 2289 2293 O
definitive 166 176 2294 2304 B-treatment
radiation 177 186 2305 2314 I-treatment
) 186 187 2314 2315 O
are 188 191 2316 2319 O
eligible 192 200 2320 2328 O
if 201 203 2329 2331 O
their 204 209 2332 2337 O
cancer 210 216 2338 2344 O
has 217 220 2345 2348 O
recurred 221 229 2349 2357 O
within 230 236 2358 2364 O
6 237 238 2365 2366 B-upper_bound
months 239 245 2367 2373 I-upper_bound
of 246 248 2374 2376 O
platinum 249 257 2377 2385 O
- 257 258 2385 2386 O
based 258 263 2386 2391 O
chemotherapy 264 276 2392 2404 O

Patients 0 8 2405 2413 O
with 9 13 2414 2418 O
EGFR 14 18 2419 2423 B-clinical_variable
or 19 21 2424 2426 O
EML4 22 26 2427 2431 O
- 26 27 2431 2432 O
ALK 27 30 2432 2435 O
mutations 31 40 2436 2445 O

Patients 0 8 2446 2454 O
with 9 13 2455 2459 O
prior 14 19 2460 2465 O
malignancies 20 32 2466 2478 B-cancer
are 33 36 2479 2482 O
allowed 37 44 2483 2490 O
, 44 45 2490 2491 O
provided 46 54 2492 2500 O
they 55 59 2501 2505 O
have 60 64 2506 2510 O
been 65 69 2511 2515 O
treated 70 77 2516 2523 O
with 78 82 2524 2528 O
curative 83 91 2529 2537 B-treatment
intent 92 98 2538 2544 I-treatment
and 99 102 2545 2548 O
have 103 107 2549 2553 O
no 108 110 2554 2556 O
evidence 111 119 2557 2565 O
of 120 122 2566 2568 O
active 123 129 2569 2575 O
disease 130 137 2576 2583 O

Pregnant 0 8 2584 2592 B-pregnancy
or 9 11 2593 2595 O
breast 12 18 2596 2602 O
- 18 19 2602 2603 O
feeding 19 26 2603 2610 O
patients 27 35 2611 2619 O
, 35 36 2619 2620 O
as 37 39 2621 2623 O
chemotherapy 40 52 2624 2636 B-treatment
is 53 55 2637 2639 O
thought 56 63 2640 2647 O
to 64 66 2648 2650 O
present 67 74 2651 2658 O
substantial 75 86 2659 2670 O
risk 87 91 2671 2675 O
to 92 94 2676 2678 O
the 95 98 2679 2682 O
fetus 99 104 2683 2688 O
/ 104 105 2688 2689 O
infant 105 111 2689 2695 O

Stage 0 5 2696 2701 B-cancer
IV 6 8 2702 2704 I-cancer
non 9 12 2705 2708 I-cancer
- 12 13 2708 2709 I-cancer
small 13 18 2709 2714 I-cancer
cell 19 23 2715 2719 I-cancer
lung 24 28 2720 2724 I-cancer
cancer 29 35 2725 2731 I-cancer
or 36 38 2732 2734 O
recurrent 39 48 2735 2744 O
disease 49 56 2745 2752 O
which 57 62 2753 2758 O
can 63 66 2759 2762 O
not 66 69 2762 2765 O
be 70 72 2766 2768 O
approached 73 83 2769 2779 O
with 84 88 2780 2784 O
curative 89 97 2785 2793 B-treatment
intent 98 104 2794 2800 I-treatment

Uncontrolled 0 12 2801 2813 O
intercurrent 13 25 2814 2826 O
illness 26 33 2827 2834 O
including 34 43 2835 2844 O
, 43 44 2844 2845 O
but 45 48 2846 2849 O
not 49 52 2850 2853 O
limited 53 60 2854 2861 O
to 61 63 2862 2864 O
: 63 64 2864 2865 O
uncontrolled 65 77 2866 2878 B-chronic_disease
ongoing 78 85 2879 2886 I-chronic_disease
infection 86 95 2887 2896 I-chronic_disease
, 95 96 2896 2897 O
symptomatic 97 108 2898 2909 O
congestive 109 119 2910 2920 B-chronic_disease
heart 120 125 2921 2926 I-chronic_disease
failure 126 133 2927 2934 I-chronic_disease
, 133 134 2934 2935 O
unstable 135 143 2936 2944 B-chronic_disease
angina 144 150 2945 2951 I-chronic_disease
pectoris 151 159 2952 2960 I-chronic_disease
, 159 160 2960 2961 O
cardiac 161 168 2962 2969 B-chronic_disease
arrhythmia 169 179 2970 2980 I-chronic_disease
, 179 180 2980 2981 O
or 181 183 2982 2984 O
psychiatric 184 195 2985 2996 B-chronic_disease
illness 196 203 2997 3004 I-chronic_disease
/ 203 204 3004 3005 I-chronic_disease
social 204 210 3005 3011 I-chronic_disease
situations 211 221 3012 3022 I-chronic_disease
that 222 226 3023 3027 O
would 227 232 3028 3033 O
limit 233 238 3034 3039 O
compliance 239 249 3040 3050 O
with 250 254 3051 3055 O
study 255 260 3056 3061 O
requirements 261 273 3062 3074 O

Untreated 0 9 3075 3084 O
central 10 17 3085 3092 B-cancer
nervous 18 25 3093 3100 I-cancer
system 26 32 3101 3107 I-cancer
metastases 33 43 3108 3118 I-cancer

Women 0 5 3119 3124 B-gender
of 6 8 3125 3127 O
childbearing 9 21 3128 3140 O
potential 22 31 3141 3150 O
and 32 35 3151 3154 O
sexually 36 44 3155 3163 O
active 45 51 3164 3170 O
males 52 57 3171 3176 B-gender
must 58 62 3177 3181 O
use 63 66 3182 3185 O
an 67 69 3186 3188 O
effective 70 79 3189 3198 O
contraception 80 93 3199 3212 O
method 94 100 3213 3219 O
during 101 107 3220 3226 O
treatment 108 117 3227 3236 B-treatment
and 118 121 3237 3240 O
for 122 125 3241 3244 O
three 126 131 3245 3250 O
months 132 138 3251 3257 O
after 139 144 3258 3263 O
completing 145 155 3264 3274 O
treatment 156 165 3275 3284 O

